Marksans Pharma Overview

  • Founded
  • 1992

Founded
  • Status
  • Public

  • Employees
  • 890

Employees
  • Stock Symbol
  • MARKSANS

Stock Symbol
  • Investments
  • 6

  • Share Price
  • $0.76

  • (As of Wednesday Closing)

Marksans Pharma General Information

Description

Marksans Pharma Ltd is a pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical formulations. It manufactures analgesics, expectorants, anti-diabetic, cardiovascular, central nervous system, gastrointestinal and oncologic drugs as well as antibiotics and antiallergic medications. The company also offers Contract Research and Manufacturing Services (CRAMS) to pharmaceutical companies. It has a global market presence with the majority of the revenue generated from North America, Europe, and the United Kingdom.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Stock Exchange
NSE
Primary Office
  • 11th Floor, Grandeur
  • Veera Desai Extension Road, Oshiwara, Andheri West
  • Mumbai, Maharashtra 400053
  • India
+91 022 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Marksans Pharma Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.76 $0.79 $0.50 - $0.86 $339M 447M 2.68M $0.06

Marksans Pharma Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020
EV 202,114 209,340 262,268 80,741
Revenue 215,716 198,654 183,921 158,948
EBITDA 42,145 39,151 45,783 26,559
Net Income 25,904 25,073 32,062 16,995
Total Assets 204,735 216,291 167,310 119,686
Total Debt 12,320 14,609 4,643 3,931
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Marksans Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Marksans Pharma‘s full profile, request access.

Request a free trial

Marksans Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Marksans Pharma Ltd is a pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical form
Drug Discovery
Mumbai, India
890 As of 2022
0000

000000

dunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exe
000000000000000
Mumbai, India
00 As of 0000
00.000
00000000000 00.000

000000

etur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
000000000000000
Noida, India
0000 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Marksans Pharma Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novartis India Corporation Mumbai, India 00 00.000 00000000000 00.000
00000000 00000000 Corporation Noida, India 0000 00000 00000000000 00000
00000 Corporation Mumbai, India 00000 00000000
000000 Formerly PE-Backed Bengaluru, India 00000 000.00 00000000 000.00
000000000000000 00 Corporation Lagos, Nigeria 00
You’re viewing 5 of 17 competitors. Get the full list »

Marksans Pharma Patents

Marksans Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220079894-A1 Stable pharmaceutical compositions Pending 11-Sep-2020 0000000000

Marksans Pharma Executive Team (2)

Name Title Board Seat Contact Info
Mark Saldanha Founder Promoter, Chairman, Managing Director & Chief Executive Officer
Jitendra Sharma Chief Financial Officer
To view Marksans Pharma’s complete executive team members history, request access »

Marksans Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Marksans Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Marksans Pharma‘s full profile, request access.

Request a free trial

Marksans Pharma Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 (00 11-Oct-2022 0000000000 Pharmaceuticals 0000 0000
000000 000000 06-Jun-2022 0000000000 00.000 Media and Information Services (B2B) 0000 0000
0000-000 0000 30-Jun-2015 0000000000 0000 Pharmaceuticals 0000 0000
000000000 28-Aug-2008 0000000000 000.00 Distributors/Wholesale 0000 0000
Hale Group 18-Jan-2008 Merger/Acquisition Holding Companies 0000 0000
You’re viewing 5 of 6 acquisitions. Get the full list »

Marksans Pharma Subsidiaries (4)

Company Name Industry Location Founded
Nova Pharmaceuticals Australasia Drug Discovery Australia 2003
000000000 Distributors/Wholesale Widnes, United Kingdom 0000
0000-000 0000 Pharmaceuticals Farmingdale, NY 0000
000000 0000000000 Media and Information Services (B2B) Dubai, United Arab Emirates
To view Marksans Pharma’s complete subsidiaries history, request access »

Marksans Pharma ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Marksans Pharma’s complete esg history, request access »

Marksans Pharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 00000 18-Jan-2008 000000000000000000 Completed
  • 00000000 000000
To view Marksans Pharma’s complete exits history, request access »